<?xml version="1.0" encoding="UTF-8"?>
<p>Baricitinib is a small, orally active molecule that inhibits Janus kinase 1 and2. The Janus kinase family, including JAK1, JAK2, JAK3, and tyrosine kinase 2 (Tyk2), has important roles in some signaling pathways through its triggering of the cytokine-induced phosphorylation of STAT that is later transported to the nucleus to regulate gene transcription [
 <xref rid="B64-pharmaceuticals-13-00096" ref-type="bibr">64</xref>,
 <xref rid="B65-pharmaceuticals-13-00096" ref-type="bibr">65</xref>].
</p>
